IPA was also found to modulate the secretion of glucagon-like peptide-1 (GLP-1) from enteroendocrine L cells as well as to exert anti-oxidative stress capacity, suggesting a potent protective effect against type 2 diabetes, one of the risk factors for developing dementia [281]. The gene discussed is GCG; the disease is type 2 diabetes mellitus.